Database for understanding diabetes complications
Tübinger Diabetes Mellitus Database (TUEDID)
This study is collecting information from adults with diabetes to see what factors might predict complications like nerve damage and eye problems, with the goal of improving patient care and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | University Hospital Tuebingen Academic / other |
| Locations | 1 site (Tübingen) |
| Trial ID | NCT03658512 on ClinicalTrials.gov |
What this trial studies
The Tübinger Diabetes Mellitus Database (TUEDID) aims to collect and analyze data from diabetic patients to identify predictive parameters for the progression of diabetes and its associated complications. This observational study will focus on characterizing patients over 18 years old to enhance risk assessment tools for late complications such as neuropathy, retinopathy, and cardiovascular issues. By gathering comprehensive data, the study seeks to improve patient quality of life and inform health economic strategies related to diabetes management.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals over 18 years old diagnosed with diabetes mellitus.
Not a fit: Patients who are unable to provide written informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better predictive tools for managing diabetes complications, ultimately improving patient outcomes.
How similar studies have performed: Other studies have explored diabetes complications, but the specific approach of this database is novel in its focus on predictive parameters.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years Exclusion Criteria: * no written informed consent
Where this trial is running
Tübingen
- University of Tuebingen, Internal medicine IV — Tübingen, Germany (Recruiting)
Study contacts
- Study coordinator: Andreas Fritsche, MD
- Email: andreas.fritsche@med.uni-tuebingen.de
- Phone: +49 7071 29 80687
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.